| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29,851 |
26,864 |
$1.03M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,939 |
15,132 |
$845K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
17,392 |
13,971 |
$496K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,303 |
5,872 |
$322K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,881 |
2,620 |
$225K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,107 |
7,762 |
$171K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,129 |
5,258 |
$58K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
631 |
564 |
$20K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
488 |
449 |
$10K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
267 |
243 |
$7K |
| 81003 |
|
3,233 |
2,646 |
$5K |
| 81025 |
|
887 |
761 |
$4K |
| 87400 |
|
179 |
111 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
223 |
175 |
$506.35 |
| 87807 |
|
15 |
14 |
$183.40 |
| 99072 |
|
2,341 |
1,718 |
$0.00 |
| 99000 |
|
383 |
343 |
$0.00 |
| A9150 |
Non-prescription drugs |
15 |
14 |
$0.00 |